Key facts
- This page summarizes Randy H. Thurman's Form 4 filing for TFF Pharmaceuticals, Inc..
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 30 Sep 2022, 17:20.
Randy H. Thurman - 29 Sep 2022 Form 4 Insider Report for TFF Pharmaceuticals, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 29 Sep 2022
- Net transaction value
- -$72,056
- SEC form
- 4
- Accepted by SEC
- 30 Sep 2022, 17:20:51 UTC
- Prior SEC filing
- 24 Mar 2022
- Next SEC filing
- 31 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Randy Thurman, by Kirk Allen Coleman, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Randy H. Thurman filed Form 4 for TFF Pharmaceuticals, Inc. on 30 Sep 2022.
Change
- Previous filing in this sequence was filed on 24 Mar 2022.
- Current net transaction value: -$72,056.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TFFP
transaction
Common Stock
Options Exercise
- Transaction value
- $100,638
- Shares
- +40,255
- Change %
- Price
- $2.50*
- Shares after
- 40,255
- Date
- 29 Sep 2022
- Ownership
- Direct
TFFP
transaction
Common Stock
Sale
- Transaction value
- $172,694
- Shares
- -40,255
- Change %
- -100%
- Price
- $4.29*
- Shares after
- 0
- Date
- 29 Sep 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TFFP
transaction
Derivative
Stock Options (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -40,255
- Change %
- -32%
- Price
- $0.000000
- Shares after
- 84,670
- Date
- 29 Sep 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,255
- Exercise price
- $2.50
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The reported shares were sold in the open market in multiple transactions at prices ranging from $4.18 to $4.57. The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to TFF Pharmaceuticals, Inc., any stockholder of TFF Pharmaceuticals, Inc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
Footnote F2
The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options.